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Ultrasound-Guided Fine-Needle
Aspiration Biopsy of Thyroid Nodules
Smaller Than 5 mm in the Maximum
Diameter: Assessment of Efficacy and
Pathological Findings
Objective: The aim of this study was to determine the efficacy of the use of an
ultrasound-guided fine-needle aspiration biopsy (US-FNAB) to diagnose thyroid
nodules smaller than 5 mm in the maximum diameter and to evaluate pathologi-
cal findings of small thyroid malignancies.
Materials and Methods: From May 2007 to April 2008, we evaluated the find-
ings of US-FNABs of small thyroid nodules less than 5 mm in the maximum diam-
eter. The cytopathological findings were retrospectively reviewed and the diag-
nostic performance of the use of an US-FNAB was examined in all patients.
Results: Of 201 small thyroid nodules in 180 patients, there were 162 ade-
quate specimens (81%). Among 180 patients, 75 patients underwent thyroid
surgery and 50 malignant and 33 benign nodules were identified based on a
pathological examination. All small malignant thyroid nodules were identified as
papillary thyroid microcarcinomas (PTMCs). There were 34 (55%) true positive, 0
(0%) false positive, 23 (37%) true negative and five (8%) false negative results for
malignancy after performing a first US-FNAB in 62 surgically confirmed nodules.
The sensitivity (87%), specificity (100%), positive predictive value (100%), nega-
tive predictive value (82%), accuracy (92%), false positive rate (0%) and false
negative rate (8%) for an US-FNAB were determined. In 23 patients with a prima-
ry PTMC, capsular invasion (9%, 2 of 23), a perithyroidal lymph node metastasis
(30%, 7 of 23), the rate of multifocality (9%, 2 of 23) and bilaterality (4%, 1 of 23)
were also determined.
Conclusion: An US-FNAB of thyroid nodules smaller than 5 mm in the maxi-
mum diameter is an effective diagnostic procedure.
n ultrasound-guided fine-needle aspiration biopsy (US-FNAB) is widely
accepted as an effective, simple and safe method for the diagnosis of head
and neck lesions, including thyroid nodules. A thyroid carcinoma less
than 10 mm in diameter is termed as a ‘microcarcinoma’ and a papillary thyroid
carcinoma (PTC) less than 10 mm in diameter is termed as a ‘papillary thyroid
microcarcinoma (PTMC)’ according to a classification by the World Health
Organization (1). To the best of our knowledge, there have been only a few reports
that have evaluated the efficacy of an US-FNAB for small thyroid nodules less than 10
mm in the maximum diameter (2-4). If there is a guarantee regarding the high efficacy
of an US-FNAB, low cost and no difficulty to perform the procedure for small thyroid
nodules, routine use of US-FNABs is likely to be adopted for the diagnosis of thyroid
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Anodules that are smaller than 10 mm in the maximum
diameter. However, no studies regarding the efficacy of an
US-FNAB for large numbers of small thyroid nodules less
than 5 mm in the maximum diameter have been
performed and only a few reports have evaluated the use
of an US-FNAB for thyroid nodules smaller than 10 mm in
diameter. Nam-Goong et al. (4) have reported the efficacy
of an US-FNAB for 25 small thyroid nodules less than 5
mm in diameter; the investigators determined a 64%
adequacy rate for the use of an US-FNAB.
The aim of this study was to determine the efficacy of an
US-FNAB to diagnose thyroid nodules smaller than 5 mm
in the maximum diameter and to evaluate pathological
findings for small malignant thyroid nodules.
MATERIALS AND METHODS
Patient Selection
Of thyroid nodules examined by the use of an US-FNAB
at our institution from May 2007 to April 2008, small
thyroid nodules less than 5 mm in the maximum diameter
were included in the study. High-resolution ultrasonogra-
phy (US) was performed with either an HDI 5000 (Phillips
Medical Systems, Bothell, WA) or iU 22 unit (Phillips
Medical Systems) using a 12-15 MHz linear probe for
guidance during the US-FNAB procedure. We obtained
informed written consent from all patients before perform-
ing US-FNABs and our institutional review board
approved this study.
Malignant sonographic findings included microcalcifica-
tions, marked hypoechogenicity, an irregular margin and a
taller-than-wide shape. The inclusion criteria for an US-
FNAB of small thyroid nodules less than 5 mm in the
maximum diameter were the following. The criteria
included a thyroid nodule with a likelihood of malignancy
as depicted on diagnostic US (n = 149), a small solid
thyroid nodule in the contralateral lobe in a patient with a
known thyroid malignancy (n = 41) or the presence of a
small solid nodule in patients at a high risk for having a
thyroid malignancy (n = 11). Risk factors for a thyroid
malignancy included cervical lymphadenopathy with a
positive cytology for a thyroid malignancy (n = 3), prior
head and neck irradiation (n = 1) and a newly developed
nodule in the opposite or remaining thyroid lobe after
surgery for a known thyroid malignancy (n = 7). A repeat
US-FNAB was performed after the first biopsy whenever
the cytology result was ‘inadequate’ or when the cytology
result did not match the sonographic impression. A
primary malignancy was defined as the largest malignant
nodule in the thyroid and a satellite malignancy was
defined as a smaller-sized, intraglandular metastatic lesion
in the ipsilateral or contralateral lobe.
Fine Needle Aspiration Biopsy Technique
An experienced radiologist (seven years experience for
performing an US-FNAB of thyroid nodules) performed an
US-FNAB with the use of a 23-gauge needle attached to a
10-ml plastic syringe. Procedures were performed under
US guidance using a perpendicular puncture and without
local anesthesia. When the needle tip reached the target
nodule, the needle was observed as a small echogenic spot
within the nodule on the US monitor (Fig. 1). After the
needle tip was placed in the appropriate area of the target
nodule, sampling was commenced using the ‘mixed
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Fig. 1. Imaging findings are shown for solitary papillary thyroid microcarcinoma (approximately 3.0 mm in maximum diameter).
A. Transverse sonogram of right lobe of thyroid shows presence of markedly hypoechoic nodule (arrow) with ill-defined margin and
taller-than-wide shape.
B. Transverse sonogram shows echogenic dot (arrow) within same nodule due to needle tip during US-fine needle aspiration biopsy.
ABsampling technique.’ This technique is an individual
sampling technique where the needle is moved up and
down for a few seconds only by movement of the wrist of
the operator and without initial aspiration under US
guidance. In all cases, only one sampling by one puncture
was taken from each nodule. After a sample was obtained,
the specimen was mounted immediately onto a glass slide.
We obtained four to six slides by performing two or three
smears from each nodule. Specimens were fixed with 95%
ethanol and were sent for pathological evaluation.
Cytopathological Examinations
The cytological diagnosis was classified as ‘benign,’
‘suspicious for a malignancy,’ ‘malignant,’ ‘indeterminate’
or ‘inadequate.’ ‘Benign’ included a normal thyroid,
nodular hyperplasia, lymphocytic thyroiditis or other
benign conditions. ‘Suspicious for a malignancy’ included
specimens showing clusters of atypical follicular cells with
some nuclear grooves. ‘Malignant’ included specimens
showing clusters of abnormal follicular cells with discrete
nuclear grooves, intranuclear pseudoinclusions or a
papillary projection. ‘Indeterminate’ referred to specimens
showing follicular cell proliferative lesions that were
indeterminate for a differential diagnosis of nodular
hyperplasia, follicular neoplasm or a follicular variant of a
PTC. In this study, an adequate specimen was defined as
having more than six clusters of follicular thyroid cells and
showing the presence of an identifiable colloid in each
preparation (5); conversely, a specimen with less than six
clusters of follicular thyroid cells in each slide was consid-
ered as ‘inadequate.’
For each primary small malignancy, capsular invasion
with tumor invasion into the thyroid capsule, a perithy-
roidal lymph node metastasis with tumor invasion into
lymph nodes in the central neck, multifocality with an
intraglandular metastasis in the ipsilateral lobe and bilater-
ality with an intraglandular metastatic lesion in the
contralateral lobe were examined.
Diagnostic Performance
Of 201 small nodules in 180 patients, 118 small nodules
in 110 patients were not removed surgically and these
nodules were excluded from the determination of diagnos-
tic indices. Of 83 nodules in 75 patients, lesions with
‘benign’ cytology were regarded as having a negative
cytology classification for a malignancy and lesions with
‘suspicious for a malignancy’ or ‘malignant’ cytology were
regarded as having as a positive cytology classification for
a malignancy. Lesions with an ‘indeterminate’ (n = 7) and
‘inadequate’ (n = 14) cytology as determined after the first
US-FNAB were excluded in the determination of the
sensitivity, specificity, predictive value, accuracy, false
positive rate and false negative rate. Ultimately, of 62
nodules in 58 patients, the sensitivity, specificity, positive
predictive value, negative predictive value, accuracy, false
positive rate and false negative rate for the first US-FNAB
were examined.
RESULTS
Of 201 small thyroid nodules (maximum diameter range,
1.0 to 5.0 mm; mean diameter, 3.4 mm) in 180 patients
(female:male = 152:28; mean age, 48.0 years; age range,
18 to 75 years), the incidence of adequate specimens was
162 (81%) after the first US-FNAB. Of 201 biopsies, the
cytology was classified as ‘benign’ for 107 lesions (53%),
‘suspicious for a malignancy’ for 22 lesions (11%),
‘malignant’ for 16 lesions (8%), ‘indeterminate’ for 17
lesions (9%) and ‘inadequate’ for 39 lesions (19%) (Table
1).
Seventy-five patients with 86 thyroid nodules underwent
thyroid surgery. Of the 75 patients, 41 patients underwent
a total thyroidectomy, 21 patients underwent a lobectomy,
12 patients underwent a subtotal thyroidectomy and one
patient underwent an isthmectomy. Fifty small malignant
thyroid nodules in 49 patients (female:male = 44:5; mean
age, 44.2 years; mean maximum diameter, 3.3 mm;
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Table 1. Cytopathological Results of Thyroid Nodules
Smaller Than 5 mm in Maximum Diameter
Lesion  Operated  Malignant 
Cytology Number  Lesion  Number 
(%) Number (%) (%)
Benign 107 (54) 28 (34) 05 (10)
Suspicious for malignancy 022 (11) 19 (23) 19 (38)
Malignant 016 (8)0 15 (18) 15 (30)
Indeterminate 017 (9)0 7 (8) 4 (8)
Inadequate 039 (19) 14 (17) 07 (14)
Total 201 83 50
Table 2. Diagnostic Performance of US-Fine Needle
Aspiration Biopsy on 62 Thyroid Nodules Smaller
Than 5 mm in Maximum Diameter
Index Incidence (%)
Sensitivity 34/39 (87)0
Specificity 23/23 (100)
Positive predictive value 34/34 (100)
Negative predictive value 23/28 (82)0
Accuracy 57/62 (92)0
False negative 5/62 (8)0
False positive 0 0 (0)maximum diameter range, 1.0 to 5.0 mm) were identified
as PTMCs based on a pathological examination and were
classified as 23 (46%) primary and 27 (54%) satellite
(smaller-sized PTCs that are distinguished from the largest
PTC) malignancy. Thirty-three small thyroid nodules with
‘benign’ cytology in 33 patients showed 28 nodular
hyperplasias and five PTMCs on the pathology after
thyroid surgery.
Of the 23 pathologically confirmed primary malignan-
cies, after the first US-FNAB two lesions (9%) were classi-
fied as ‘benign,’ eight lesions (35%) were classified as
‘suspicious for a malignancy,’ 10 lesions (44%) were classi-
fied as ‘malignant,’ two lesions (9%) were classified as
‘indeterminate’ and one lesion (4%) was classified as
‘inadequate’ based on the cytology. Of five (two benign,
tow indeterminate, and one inadequate) pathologically
confirmed primary malignant nodules with negative
cytology results after the first biopsy, four lesions were
classified as ‘suspicious for a malignancy’ after a second
biopsy and one lesion was classified as ‘benign’ after a
second biopsy. Although one pathologically confirmed
malignant nodule demonstrated negative cytology results
even after two consecutive US-FNABs, the patient
underwent thyroid surgery because of the high likelihood
of a malignancy as found on diagnostic US.
Of the 27 pathologically confirmed satellite malignancies
after the first US-FNAB, three lesions (11%) were classi-
fied as ‘benign,’ 10 lesions (37%) were classified as
‘suspicious for a malignancy,’ six lesions (22%) were classi-
fied as ‘malignant,’ two lesions (7%) were classified as
‘indeterminate’ and six lesions (22%) were classified as
‘inadequate’ based on the cytology. Eleven satellite
malignant nodules that showed a negative cytology after
the first biopsy were surgically removed without an
additional biopsy as they showed a combined primary
thyroid malignancy on simultaneous US-FNABs.
For the first US-FNAB of 62 nodules, there were 34
(55%) true positives, 0 (0%) false positives, 23 (37%) true
negatives and five (8%) false negatives. The sensitivity
(87%), specificity (100%), positive predictive value
(100%), negative predictive value (82%), accuracy (92%),
false positive rate (0%) and false negative rate (8%) after
an US-FNAB for nodules smaller than 5 mm in the
maximum diameter were determined (Table 2).
Twenty-three patients with a primary PTMC smaller
than 5 mm in the maximum diameter underwent thyroid
surgery. Capsular extension (9%, 2 of 23), a perithyroidal
lymph node metastasis (30%, 7 of 23), multifocality (9%,
2 of 23) and bilaterality (4%, 1 of 23) were identified.
Thyroid surgery for these patients included a total
thyroidectomy (n = 7), a subtotal thyroidectomy (n = 4)
and a lobectomy (n = 12).
Twenty-one patients (12%, 21 of 180) experienced mild
pain that persisted for several minutes during or after the
biopsy, but the pain subsided spontaneously without
medication. Major complications such as significant
hemorrhage or a secondary infection were not observed.
DISCUSSION
US-FNAB is the least invasive, most simple and most
accurate method to evaluate a thyroid nodular lesion.
However, the size criterion is still controversial for thyroid
nodules evaluated on an US-FNAB. The American
Thyroid Association (ATA) guidelines suggest that, in
general, only nodules larger than 10 mm in diameter
should be evaluated as the nodules have the potential to
represent a clinically significant cancer (6). Occasionally,
there may also be nodules less than 10 mm in the
maximum diameter that require evaluation due to
suspicious US findings and/or a patient history of thyroid
cancer (7). The Society of Radiologists in Ultrasound
Consensus Statement suggests performing US-FNAB on
thyroid nodules 10 mm or greater in the maximum
diameter when the nodules exhibit microcalcifications or
other US features associated with thyroid cancer, as an
early diagnosis of thyroid cancer does not guarantee a
decrease in recurrence or the mortality rate (8). Burman
(9) also mentioned that irrespective of which suggested
minimum measurement or guideline is used, the most
critical requirement is to monitor these patients with
periodic clinical and US examinations. However, many
authorities suggest that it is important to diagnose thyroid
cancer at an early stage to reduce the risk of recurrence or
mortality (10, 11).
There are a few reports that have evaluated the use of an
US-FNAB of thyroid nodules less than 5 mm in the
maximum diameter. Nam-Goong et al. (4) found a 64%
adequate sampling rate for 25 small thyroid nodules less
than 5 mm in diameter, but the study did not indicate
whether the maximum or minimum diameter of the
nodules had been measured. Roti et al. (12) retrospectively
analyzed 243 patients with pathologically confirmed
PTMCs, but the investigators did not comment on the
adequacy or efficacy of US-FNABs for the thyroid
nodules.
In this study, the sensitivity and negative predictive
value of performing an US-FNAB for the diagnosis of
small thyroid nodules equal to or less than 5 mm in the
maximum diameter were relatively low as compared with
values obtained for other diagnostic indices; however, the
specificity and positive predictive value were high. To the
Kim et al.
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previously published reports, although the sensitivity and
negative predictive value of an US-FNAB for small-
diameter thyroid nodules were 87% and 82%, respec-
tively. However, five ‘benign’ nodules identified after the
first US-FNAB were later confirmed as PTMCs after
thyroid surgery and were determined as false negative
cytologies (8%), but false positive cytology was not
detected. This false negative rate for an US-FNAB of small
thyroid nodules less than 5 mm in the maximum diameter
is relatively high; however, this rate may be subject to
change if non-operated nodules are surgically confirmed.
The size of the five PTMCs with false negative cytology as
determined after the first US-FNAB was less than 3 mm in
the maximum diameter as determined on diagnostic US.
Therefore, we assumed that the relatively high false
negative rate was due to sampling of primarily normal
tissue rather than the PTMC during the ‘to-and-fro’ cell
acquisition.
In the present study, the incidence of capsular invasion
of a PTMC smaller than 5 mm in the maximum diameter
was 9% (2 of 23), which was relatively low as compared to
the studies of Roti et al. (12) and Chow et al. (13). Roti et
al. (12) reported that two patients (2%, 2 of 86) with
thyroid cancers less than 5 mm had regional lymph node
metastases, but in the present study, 23 primary PTMCs
equal to or less than 5 mm in the maximum diameter
showed a perithyroidal lymph node metastasis (30%, 7 of
23). We presume that the high rate of a perithyroidal
lymph node metastasis in the present study might be
associated with the relatively high incidence of the subcap-
sular location of PTMCs. Regarding the multifocality of a
PTMC, Roti et al. (12) and Chow et al. (13) reported that
32% (78 of 243) and 31% (63 of 203) of patients were
indentified with multifocal lesions, respectively, but the
investigators in both studies did not describe PTMCs less
than 5 mm in the maximum diameter. Roti et al. (12)
found that the incidence rate of bilaterality of a PTMC was
19% (45 of 243), but the investigators did not separately
mention the bilaterality rate of a PTMC less than 5 mm in
the maximum diameter. In the present study, multifocality
(9%, 2 of 23) and bilaterality (4%, 1 of 23) were identi-
fied. To the best of our knowledge, no large-scale study
has examined the incidence of regional lymph node
metastases, multifocality and bilaterality of a PTMC less
than 5 mm in the maximum diameter.
In our study, significant complications related to
performing an US-FNAB were not detected in any of the
patients. Several factors have been associated with a low
incidence of complications with the use of the US-FNAB
procedure, including one sampling with one puncture,
shortening of the procedure time, accurate targeting and
watching the needle tip during the biopsy. In particular,
continuous watching of the needle tip on the US monitor
during the entire procedure is important in order to
prevent arterial injury to the carotid or vertebral artery.
This study has several limitations. First, this study was
not a large-scale study. Second, thyroid surgery for the
thyroid malignancies included total, subtotal and a
lobectomy and regional lymph node resection was not
performed for all of the PTCs. Third, we did not consider if
the presence of underlying diffuse thyroid disease
influenced the outcome of the US-FNABs. Ceresini et al.
(14) have suggested that in cases of underlying diffuse
thyroid disease, such as thyroiditis or diffuse goiter, the
outcome of an US-FNAB for small thyroid nodules might
have resulted in an negative influence. Finally, our
technique of performing an US-FNAB of thyroid nodules is
not a standard technique.
The importance of early diagnosis of thyroid cancer in
patients at low risk remains uncertain as thyroid cancers
are typically slow growing and are associated with a low
morbidity and mortality (6, 8, 15). However, we believe
that early diagnosis of thyroid malignancies less than 5 mm
in the maximum diameter by the use of diagnostic US and
an US-FNAB is helpful to improve patient morbidity rates
for poorly differentiated thyroid malignancies. In addition,
in our study, the diagnosis of 27 satellite small PTMCs
after an US-FNAB influenced the decision regarding the
type of thyroid surgery (e.g., a lobectomy or total
thyroidectomy).
In conclusion, an US-FNAB of thyroid nodules smaller
than 5 mm in the maximum diameter is an effective
diagnostic method if performed by an experienced radiolo-
gist. In the present study, primary PTMCs smaller than 5
mm in the maximum diameter had a low incidence of
capsular invasion, multifocality and bilaterality, but a
relatively high incidence of perithyroidal lymph node
metastases.
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